Literature DB >> 6438501

Induction of 6-thioguanine-resistant mutants and SCEs by 3 chemical mutagens (EMS, ENU and MMC) in cultured human blood lymphocytes.

H J Evans.   

Abstract

Human peripheral blood lymphocytes were exposed in vitro to a series of graded concentrations of ethyl methanesulphonate (EMS) or N-ethyl-N-nitrosourea (ENU) or mitomycin C (MMC) to: (a) estimate the frequency of thioguanine-resistant (TGr) cells using the T-cell cloning technique, (b) examine the induction of sister-chromatid exchanges (SCEs) by these chemicals in the lymphocytes of the same blood sample used to study the TGr cells, and (c) assess the nature of correlations between these two biological end-points. The frequencies of TGr cells as well as those of SCEs increased with increasing concentration of the chemicals studied. For EMS and ENU, the increases were consistent with linear dose-effect relationships. There was a linear relationship between SCEs and mutation induction for all 3 chemicals; but the ratio of induced SCEs to induced mutants was different for the different chemicals, being highest for ENU, followed by EMS and MMC, in that order. The basis for these differences is discussed in the light of what is known about the relationships between chemical reactivity patterns and the resultant biological effects of these chemicals.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6438501     DOI: 10.1016/0027-5107(84)90161-1

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  2 in total

1.  Spontaneous 6-thioguanine-resistant lymphocytes in Fanconi anemia patients and their heterozygous parents.

Authors:  E Wunder; T M Schroeder
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

2.  Attempts to use the HPRT-assay as an automated short-term monitor for an acute exposure to mutagens.

Authors:  A Johannisson; B Eriksson; H Amnéus; G Zetterberg
Journal:  Cell Biol Toxicol       Date:  1992 Oct-Dec       Impact factor: 6.691

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.